연구 및 보고서
2026년 9월 13일•1분 읽기
KIMCo Foundation and AI New Drug Institute Join 2026 Pharma-Bio Venture Collaboration Project
KIMCo Foundation and the AI New Drug Research Institute will support the Ministry of SMEs’ 2026 Pharma‑Bio Venture Collaboration R&D project, covering 30 AI‑driven drug discovery tasks.
연구 및 보고서
2026년 9월 13일•1분 읽기
ArcGen Bio selected as lead institute for govt pharma‑bio venture collaboration project
ArcGen Bio has been chosen as the lead research institute for the Ministry of SMEs and Startups' pharma‑bio venture collaboration project, receiving 30 billion KRW over three years, with LG Chem joining as a co‑research partner on a multi‑specific T‑cell engager immuno‑oncology drug.
연구 및 보고서
2026년 8월 31일•1분 읽기
Samsung Bioepis, Proteina Expand AI Antibody Development
Samsung Bioepis and Proteina signed a license option agreement to advance AI‑driven antibody drug discovery from candidate identification to commercialization, building on a government AI project.
연구 및 보고서
2026년 8월 29일•1분 읽기
Mokam Life Science Institute partners with ST Pharm on AI‑driven RNA design technology
Mokam Life Science Institute and ST Pharm have signed a joint R&D agreement to develop AI‑based RNA design and optimization technology, aiming to boost next‑generation RNA therapeutic development.